PVL
- $3.35mill cash, enterprise value= $7.5mill no debt. 4.2mill market cap.Low shares on issue, can run
-New director appointments + substantial holders
Business Model:
- Signed a Science Collaboration Agreementwith the University of Melbourne. “The Company is working towards signing othersimilar agreements with other Australian Universities over the coming months.”
Have stakes in several companies including biotech companies:
- Ferronova: Super-paramagneticiron oxide nanoparticle (SPION) platform to improve surgical staging andtherapy in solid tumour cancers
- Objective Acuity:
firstobjective vision screening and testing platform based on a functional visionmeasurement
Valuation:
PVL has $3.35mill cash + a $4.2mill inits portfolio valuation by having a shareholding stake in emerging companies. What’simportant to note is that that their portfolio valuation has high probability torise given these emerging companies have potential to be significant game-changersIMHO. All in all, PVL has an enterprise value of $7.5mill.
I will continue to accumulate at everypullback. Thanks
